New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer

This study was to examine serum CA19-9 levels in patients with pancreatic cancer according to Lewis status.

Source: Pancreatology - August 9, 2018 Category: Gastroenterology Authors: Guopei Luo, Zhiyao Fan, He Cheng, Kaizhou Jin, Meng Guo, Yu Lu, Chao Yang, Kun Fan, Qiuyi Huang, Jiang Long, Liang Liu, Jin Xu, Renquan Lu, Quanxing Ni, Andrew L. Warshaw, Chen Liu, Xianjun Yu Source Type: research